NCT02191332View on ClinicalTrials.gov

Observational Study in Patients With HIV Infection Type 1 After Switching to a Viramune®-Containing Therapy Regimen

CompletedOBSERVATIONAL
Enrollment

147

Participants

Timeline

Start Date

December 31, 1999

Primary Completion Date

November 30, 2001

Conditions
HIV Infections
Interventions
DRUG

Viramune

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02191332 - Observational Study in Patients With HIV Infection Type 1 After Switching to a Viramune®-Containing Therapy Regimen | Biotech Hunter | Biotech Hunter